+499.5%
MRNA vs LH
+20.0%
+479.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.4% | -0.8% | -0.5% |
| 7D | +5.5% | -2.5% | +7.9% | +8.6% |
| 30D | +158.7% | +4.3% | +154.4% | +153.3% |
| 3M | +182.1% | +25.5% | +156.6% | +151.0% |
| 6M | +151.8% | +17.0% | +134.9% | +134.8% |
| YTD | +393.6% | +31.3% | +362.3% | +320.2% |
| 1Y | +499.5% | +20.0% | +479.5% | +433.3% |
| All | +499.5% | +20.0% | +479.5% | +433.3% |
Cumulative growth
Daily Returns
Daily percentage return beside LH.
Daily Out/Under-Performance
Portfolio return minus LH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling